T
TSC Top Supplements China
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | C | 8 | 6.3 | 4.8 | 8.0 | 4 Sep 2025 |
| Cagrilintide | D | 5 | 5.5 | 3.4 | 8.0 | 9 Jul 2025 |
| BPC-157 | E | 12 | 5.6 | 0.0 | 8.8 | 10 Sep 2025 |
| Retatrutide | E | 43 | 7.2 | 2.0 | 10.0 | 3 Jun 2025 |
| Tesamorelin | E | 7 | 4.2 | 0.0 | 7.8 | 27 Jun 2025 |
| Tirzepatide | E | 24 | 6.8 | 1.6 | 9.8 | 3 Jun 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 |
| AA Water | C | 8 | 6.2 | 4.2 | 8.3 | 20 May 2026 |
| BPC-157 Arg Oral | X | 1 | 9.6 | 9.6 | 9.6 | 11 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | C | 9 | 7.0 | 4.8 | 8.4 | 23 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | C | 3 | 7.8 | 7.3 | 8.5 | 21 May 2026 |
| Chonluten | C | 4 | 6.0 | 5.5 | 6.5 | 20 May 2026 |
| CJC-1295 With DAC | C | 3 | 5.4 | 4.9 | 6.0 | 20 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | C | 4 | 6.7 | 5.6 | 7.4 | 25 May 2026 |
| Crystagen | C | 8 | 6.5 | 4.2 | 8.4 | 17 May 2026 |
| Dihexa | C | 8 | 6.5 | 4.4 | 10.0 | 25 May 2026 |
| Equipoise (Boldenone Undecylenate) | C | 2 | 5.8 | 4.2 | 7.4 | 23 May 2026 |
| GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | C | 7 | 6.6 | 5.1 | 8.7 | 23 May 2026 |
| Glutathione | C | 8 | 7.3 | 5.7 | 8.7 | 21 May 2026 |
| Gonadorelin | C | 3 | 8.5 | 7.8 | 9.9 | 19 Jan 2026 |
| HMG | X | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 |
| Humanin | C | 5 | 7.4 | 5.4 | 9.3 | 21 May 2026 |
| Hyaluronic acid | C | 6 | 6.7 | 5.4 | 8.4 | 26 Jan 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | C | 9 | 6.3 | 4.3 | 9.2 | 23 May 2026 |
| MOTS-C | C | 7 | 5.7 | 2.6 | 8.5 | 20 May 2026 |
| N-Acetyl Epitalon Amidate | C | 5 | 6.2 | 5.7 | 6.8 | 24 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | C | 9 | 6.9 | 5.0 | 8.7 | 17 May 2026 |
| NAD+ | C | 9 | 6.2 | 3.4 | 8.9 | 19 Jan 2026 |
| Orforglipron | C | 2 | 5.8 | 5.4 | 6.3 | 26 Jan 2026 |
| P21 | C | 4 | 6.9 | 6.0 | 9.2 | 25 May 2026 |
| PEG MGF | C | 9 | 6.0 | 3.6 | 8.5 | 21 May 2026 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | C | 2 | 5.5 | 5.5 | 5.6 | 25 May 2026 |
| Selank 10mg + Semax 10mg Blend | C | 9 | 6.1 | 3.7 | 9.0 | 21 May 2026 |
| Semaglutide Oral | C | 9 | 6.5 | 4.5 | 8.6 | 24 May 2026 |
| Superdrol | C | 5 | 8.2 | 6.5 | 9.6 | 21 May 2026 |
| Tadalafil Raw | C | 3 | 6.1 | 4.6 | 7.2 | 24 May 2026 |
| Trenbolone Enanthate | X | 1 | 5.6 | 5.6 | 5.6 | 14 Jan 2025 |
| Turinabol | C | 8 | 7.7 | 6.7 | 9.3 | 17 May 2026 |
| Winstrol Water (Stanozolol) | C | 8 | 6.9 | 5.0 | 8.9 | 24 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.6 | 50mg | 47.0mg | -5.9% | 99.61% | Lab C |
| 25 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.8 | 10mg | 9.0mg | -9.8% | 99.68% | Lab F |
| 25 May 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 7.7 | 300mg/ml | 308.2mg/ml | +2.7% | 95.15% | Lab B |
| 25 May 2026 | Glutathione | 6.6 | 30mg | 34.9mg | +16.3% | 96.77% | Lab E |
| 25 May 2026 | MOTS-C | 6.9 | 10mg | 12.5mg | +24.6% | 96.81% | Lab E |
| 25 May 2026 | Orforglipron | 5.1 | 10mg | 10.5mg | +5.0% | 99.66% | Lab G |
| 25 May 2026 | Selank 10mg + Semax 10mg Blend | 5.6 | 2mg | 2.3mg | +13.8% | 98.10% | Lab G |
| 25 May 2026 | Winstrol Water (Stanozolol) | 6.4 | 200mg/ml | 220.7mg/ml | +10.4% | 96.69% | Lab F |
| 24 May 2026 | AA Water | 5.0 | 15mg | 15.3mg | +1.8% | 96.55% | Lab D |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.9 | 5mg | 6.2mg | +23.1% | 97.86% | Lab E |
| 24 May 2026 | Dihexa | 5.6 | 25mg | 22.0mg | -12.0% | 95.82% | Lab E |
| 24 May 2026 | Hyaluronic acid | 6.6 | 30mg | 32.5mg | +8.2% | 97.95% | Lab B |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.0 | 2mg | 1.8mg | -10.8% | 98.92% | Lab F |
| 24 May 2026 | PEG MGF | 6.1 | 30mg | 31.0mg | +3.4% | 96.88% | Lab C |
| 24 May 2026 | PEG MGF | 6.4 | 5mg | 5.5mg | +9.5% | 97.17% | Lab E |
| 24 May 2026 | Tirzepatide | 1.6 | 5mg | 2.62mg | -47.6% | 88.09% | Lab E |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.4 | 2mg | 2.5mg | +23.2% | 96.21% | Lab C |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.8 | 50mg | 58.9mg | +17.8% | 97.12% | Lab G |
| 24 May 2026 | P21 | 5.5 | 20mg | 17.0mg | -14.8% | 95.97% | Lab A |
| 24 May 2026 | PEG MGF | 5.3 | 50mg | 45.9mg | -8.3% | 95.59% | Lab B |
| 24 May 2026 | Semaglutide Oral | 4.3 | 20mg | 22.1mg | +10.5% | 99.95% | Lab G |
| 24 May 2026 | AA Water | 7.6 | 2mg | 2.4mg | +18.8% | 95.67% | Lab A |
| 24 May 2026 | BPC-157 Arg Oral | 9.7 | 20mg | 17.0mg | -14.9% | 99.74% | Lab A |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.8 | 30mg | 34.9mg | +16.4% | 95.27% | Lab E |
| 24 May 2026 | Chonluten | 5.7 | 2mg | 1.9mg | -3.6% | 95.31% | Lab A |
| 24 May 2026 | Crystagen | 5.2 | 10mg | 11.1mg | +11.4% | 95.35% | Lab E |
| 24 May 2026 | Crystagen | 7.0 | 5mg | 6.1mg | +22.0% | 96.42% | Lab G |
| 24 May 2026 | Dihexa | 8.5 | 25mg | 26.9mg | +7.7% | 99.44% | Lab A |
| 24 May 2026 | Glutathione | 6.5 | 5mg | 5.8mg | +15.1% | 96.36% | Lab G |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.2 | 15mg | 14.7mg | -1.8% | 99.65% | Lab B |
| 24 May 2026 | NAD+ | 4.9 | 30mg | 28.2mg | -5.9% | 95.10% | Lab G |
| 24 May 2026 | NAD+ | 5.0 | 15mg | 17.3mg | +15.6% | 98.16% | Lab B |
| 24 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 4.1 | 5g | 5.4g | +8.4% | 98.80% | Lab C |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 6.7 | 2mg | 1.8mg | -11.7% | 97.72% | Lab G |
| 24 May 2026 | Semaglutide Oral | 7.2 | 20mg | 24.6mg | +23.0% | 99.06% | Lab F |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.9 | 50mg | 47.4mg | -5.1% | 97.17% | Lab C |
| 24 May 2026 | Chonluten | 5.8 | 15mg | 15.3mg | +1.7% | 95.26% | Lab D |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.4 | 15mg | 13.3mg | -11.1% | 97.54% | Lab A |
| 24 May 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 8.5 | 250mg/ml | 238.9mg/ml | -4.5% | 99.34% | Lab A |
| 24 May 2026 | Tirzepatide | 7.8 | 30mg | 31.2mg | +4.0% | 99.80% | Lab G |
| 24 May 2026 | AA Water | 5.6 | 5mg | 5.4mg | +8.2% | 95.43% | Lab C |
| 24 May 2026 | Gonadorelin | 8.8 | 15mg | 14.5mg | -3.5% | 97.49% | Lab A |
| 23 May 2026 | Retatrutide | 10.0 | 5mg | 4.8mg | -4.0% | 99.90% | Lab E |
| 23 May 2026 | Humanin | 7.2 | 30mg | 35.8mg | +19.4% | 98.84% | Lab A |
| 23 May 2026 | MOTS-C | 4.8 | 30mg | 31.8mg | +5.9% | 96.22% | Lab C |
| 23 May 2026 | MOTS-C | 4.0 | 30mg | 32.1mg | +6.8% | 98.18% | Lab F |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 5.0 | 10mg | 11.4mg | +13.9% | 99.45% | Lab D |
| 23 May 2026 | Superdrol | 9.1 | 100mg | 95.9mg | -4.1% | 95.15% | Lab C |
| 23 May 2026 | Humanin | 6.0 | 20mg | 24.8mg | +24.1% | 97.21% | Lab G |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.3 | 10mg | 11.6mg | +15.6% | 96.32% | Lab E |
| 23 May 2026 | PEG MGF | 6.8 | 2mg | 1.9mg | -4.4% | 96.67% | Lab E |
| 23 May 2026 | PEG MGF | 4.5 | 2mg | 2.4mg | +21.8% | 97.22% | Lab B |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 6.9 | 15mg | 16.9mg | +12.7% | 98.30% | Lab A |
| 23 May 2026 | Turinabol | 6.9 | 100mg | 110.5mg | +10.5% | 97.80% | Lab E |
| 21 May 2026 | Cagrilintide | 4.3 | 5mg | 4.56mg | -8.8% | 98.46% | Lab E |
| 21 May 2026 | Chonluten | 4.6 | 50mg | 43.6mg | -12.7% | 96.72% | Lab G |
| 21 May 2026 | Crystagen | 7.3 | 30mg | 27.8mg | -7.3% | 99.55% | Lab F |
| 21 May 2026 | Dihexa | 8.1 | 20mg | 23.6mg | +18.0% | 95.17% | Lab G |
| 21 May 2026 | Dihexa | 5.8 | 100mg | 94.3mg | -5.7% | 96.60% | Lab G |
| 21 May 2026 | Hyaluronic acid | 6.6 | 2mg | 1.7mg | -13.9% | 96.04% | Lab D |
| 21 May 2026 | N-Acetyl Epitalon Amidate | 5.3 | 2mg | 2.4mg | +19.1% | 96.74% | Lab E |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.1 | 2mg | 2.2mg | +10.2% | 99.23% | Lab G |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.8 | 30mg | 25.9mg | -13.8% | 98.43% | Lab B |
| 21 May 2026 | Tirzepatide | 4.6 | 30mg | 33.3mg | +11.0% | 99.16% | Lab E |
| 21 May 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 5.7 | 200mg/ml | 177.8mg/ml | -11.1% | 97.34% | Lab C |
| 21 May 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 6.9 | 200mg/ml | 231.0mg/ml | +15.5% | 95.69% | Lab G |
| 21 May 2026 | Glutathione | 7.4 | 5mg | 5.2mg | +3.8% | 95.38% | Lab E |
| 21 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 5.9 | 30mg | 27.4mg | -8.8% | 97.08% | Lab D |
| 21 May 2026 | MOTS-C | 4.9 | 20mg | 22.6mg | +13.1% | 95.98% | Lab C |
| 20 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.1 | 5mg | 5.7mg | +14.2% | 96.08% | Lab C |
| 20 May 2026 | NAD+ | 5.4 | 20mg | 22.6mg | +13.1% | 95.32% | Lab B |
| 20 May 2026 | Turinabol | 8.8 | 100mg | 97.0mg | -3.0% | 99.84% | Lab G |
| 19 May 2026 | CJC-1295 With DAC | 5.6 | 20mg | 24.0mg | +19.8% | 98.28% | Lab G |
| 19 May 2026 | N-Acetyl Epitalon Amidate | 5.8 | 30mg | 31.8mg | +6.0% | 97.71% | Lab A |
| 17 May 2026 | Tirzepatide | 4.3 | 10mg | 10.7mg | +7.0% | 96.92% | Lab E |
| 17 May 2026 | AA Water | 4.7 | 5mg | 6.2mg | +23.2% | 98.00% | Lab G |
| 17 May 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 6.6 | 300mg/ml | 290.2mg/ml | -3.3% | 98.59% | Lab B |
| 17 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.6 | 10mg | 9.2mg | -8.1% | 99.84% | Lab D |
| 17 May 2026 | Turinabol | 8.2 | 100mg | 86.8mg | -13.2% | 96.53% | Lab G |
| 17 May 2026 | Winstrol Water (Stanozolol) | 5.7 | 300mg/ml | 291.9mg/ml | -2.7% | 99.85% | Lab C |
| 29 Jan 2026 | Retatrutide | 6.7 | 10mg | 10.3mg | +3.0% | 99.36% | Lab E |
| 29 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 6.2 | 50mg | 44.8mg | -10.4% | 96.96% | Lab B |
| 29 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 5.8 | 20mg | 19.5mg | -2.4% | 97.96% | Lab G |
| 29 Jan 2026 | Equipoise (Boldenone Undecylenate) | 5.2 | 300mg/ml | 323.2mg/ml | +7.7% | 97.18% | Lab C |
| 29 Jan 2026 | PEG MGF | 6.7 | 50mg | 61.9mg | +23.7% | 96.48% | Lab D |
| 29 Jan 2026 | Semaglutide Oral | 5.9 | 10mg | 9.0mg | -9.5% | 98.37% | Lab D |
| 29 Jan 2026 | Turinabol | 10.0 | 100mg | 112.3mg | +12.3% | 95.89% | Lab E |
| 29 Jan 2026 | Turinabol | 9.0 | 50mg | 55.0mg | +10.0% | 99.22% | Lab D |
| 29 Jan 2026 | Turinabol | 6.7 | 50mg | 50.7mg | +1.4% | 99.97% | Lab B |
| 29 Jan 2026 | Winstrol Water (Stanozolol) | 5.9 | 250mg/ml | 282.9mg/ml | +13.2% | 97.22% | Lab C |
| 26 Jan 2026 | Gonadorelin | 7.2 | 20mg | 20.0mg | +0.1% | 97.11% | Lab F |
| 26 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 5.5 | 10mg | 11.5mg | +14.7% | 99.54% | Lab E |
| 26 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.1 | 5mg | 5.3mg | +5.5% | 97.58% | Lab C |
| 26 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.5 | 20mg | 21.9mg | +9.6% | 99.87% | Lab A |
| 26 Jan 2026 | Semaglutide Oral | 4.9 | 100mg | 120.0mg | +20.0% | 96.72% | Lab C |
| 26 Jan 2026 | Superdrol | 7.1 | 10mg | 8.7mg | -13.3% | 99.11% | Lab F |
| 26 Jan 2026 | Tadalafil Raw | 4.6 | 1g | 0.9g | -8.4% | 99.55% | Lab G |
| 19 Jan 2026 | Chonluten | 6.8 | 30mg | 28.5mg | -5.0% | 98.92% | Lab G |
| 19 Jan 2026 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 6.0 | 200mg/ml | 229.6mg/ml | +14.8% | 99.23% | Lab G |
| 19 Jan 2026 | Glutathione | 7.3 | 20mg | 20.7mg | +3.4% | 97.96% | Lab D |
| 19 Jan 2026 | Hyaluronic acid | 7.8 | 50mg | 62.2mg | +24.3% | 98.44% | Lab B |
| 19 Jan 2026 | Turinabol | 6.9 | 25mg | 30.7mg | +22.7% | 98.01% | Lab A |
| 9 Jan 2026 | AA Water | 6.3 | 15mg | 14.9mg | -0.8% | 97.90% | Lab D |
| 9 Jan 2026 | Crystagen | 5.1 | 2mg | 2.3mg | +14.7% | 95.55% | Lab A |
| 9 Jan 2026 | Glutathione | 8.1 | 50mg | 52.9mg | +5.9% | 96.96% | Lab D |
| 9 Jan 2026 | Hyaluronic acid | 8.3 | 5mg | 6.1mg | +21.4% | 96.83% | Lab C |
| 9 Jan 2026 | Hyaluronic acid | 5.7 | 20mg | 24.6mg | +23.0% | 95.08% | Lab C |
| 9 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.7 | 20mg | 22.6mg | +13.1% | 95.29% | Lab D |
| 9 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.0 | 30mg | 29.9mg | -0.2% | 95.82% | Lab B |
| 9 Jan 2026 | NAD+ | 5.7 | 50mg | 55.7mg | +11.4% | 95.64% | Lab D |
| 9 Jan 2026 | Superdrol | 7.7 | 20mg | 20.4mg | +2.1% | 99.06% | Lab D |
| 7 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 7.4 | 2mg | 2.1mg | +4.7% | 95.11% | Lab F |
| 7 Jan 2026 | CJC-1295 With DAC | 5.2 | 30mg | 29.9mg | -0.4% | 98.80% | Lab C |
| 7 Jan 2026 | Crystagen | 7.0 | 10mg | 9.8mg | -2.4% | 98.40% | Lab A |
| 7 Jan 2026 | Dihexa | 7.2 | 25mg | 22.6mg | -9.7% | 95.17% | Lab F |
| 7 Jan 2026 | MOTS-C | 7.3 | 10mg | 12.4mg | +24.1% | 99.24% | Lab F |
| 7 Jan 2026 | N-Acetyl Epitalon Amidate | 7.1 | 10mg | 9.8mg | -1.9% | 99.30% | Lab F |
| 7 Jan 2026 | Winstrol Water (Stanozolol) | 7.7 | 300mg/ml | 265.0mg/ml | -11.7% | 97.22% | Lab C |
| 6 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.1 | 5mg | 5.0mg | +0.4% | 99.15% | Lab E |
| 6 Jan 2026 | Dihexa | 6.2 | 100mg | 104.2mg | +4.2% | 96.38% | Lab A |
| 6 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.4 | 2mg | 1.8mg | -11.6% | 98.75% | Lab B |
| 6 Jan 2026 | N-Acetyl Epitalon Amidate | 7.3 | 50mg | 50.9mg | +1.8% | 96.35% | Lab G |
| 6 Jan 2026 | NAD+ | 5.2 | 20mg | 17.6mg | -12.0% | 96.24% | Lab D |
| 6 Jan 2026 | P21 | 9.2 | 20mg | 20.4mg | +1.8% | 95.84% | Lab A |
| 6 Jan 2026 | Semaglutide Oral | 4.5 | 10mg | 9.7mg | -3.1% | 95.25% | Lab G |
| 6 Jan 2026 | Superdrol | 8.5 | 50mg | 44.3mg | -11.4% | 95.49% | Lab F |
| 6 Jan 2026 | Tadalafil Raw | 5.8 | 500g | 557.2g | +11.4% | 99.09% | Lab G |
| 6 Jan 2026 | Trenbolone Enanthate | 7.1 | 300mg/ml | 371.4mg/ml | +23.8% | 96.17% | Lab E |
| 29 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.9 | 5mg | 5.5mg | +10.7% | 95.48% | Lab C |
| 29 Dec 2025 | Glutathione | 7.9 | 5mg | 6.2mg | +24.8% | 96.04% | Lab D |
| 29 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.3 | 15mg | 18.4mg | +22.6% | 99.47% | Lab D |
| 29 Dec 2025 | Selank 10mg + Semax 10mg Blend | 6.2 | 5mg | 4.6mg | -8.7% | 99.46% | Lab E |
| 29 Dec 2025 | Superdrol | 9.0 | 25mg | 28.3mg | +13.1% | 96.27% | Lab A |
| 12 Dec 2025 | CJC-1295 With DAC | 7.8 | 10mg | 11.4mg | +13.6% | 97.14% | Lab F |
| 12 Dec 2025 | HMG | 7.2 | 30mg | 26.1mg | -13.0% | 96.34% | Lab E |
| 12 Dec 2025 | Humanin | 6.3 | 15mg | 17.6mg | +17.6% | 95.55% | Lab D |
| 12 Dec 2025 | MOTS-C | 5.5 | 30mg | 26.2mg | -12.6% | 96.00% | Lab A |
| 12 Dec 2025 | NAD+ | 6.7 | 20mg | 24.1mg | +20.7% | 97.82% | Lab F |
| 12 Dec 2025 | Semaglutide Oral | 8.6 | 100mg | 92.1mg | -7.9% | 95.93% | Lab G |
| 12 Dec 2025 | Tadalafil Raw | 6.4 | 1g | 1.0g | -4.1% | 96.82% | Lab E |
| 12 Dec 2025 | Turinabol | 8.1 | 25mg | 25.8mg | +3.1% | 98.57% | Lab A |
| 5 Dec 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 7.4 | 5g | 5.0g | -0.4% | 95.39% | Lab G |
| 5 Dec 2025 | Glutathione | 6.5 | 2mg | 1.8mg | -12.5% | 95.06% | Lab C |
| 5 Dec 2025 | Glutathione | 8.4 | 15mg | 15.6mg | +3.7% | 95.50% | Lab F |
| 5 Dec 2025 | Humanin | 6.9 | 50mg | 56.2mg | +12.5% | 98.10% | Lab D |
| 23 Nov 2025 | Crystagen | 7.4 | 15mg | 13.2mg | -11.9% | 98.89% | Lab G |
| 23 Nov 2025 | Hyaluronic acid | 8.2 | 50mg | 54.2mg | +8.3% | 99.29% | Lab B |
| 23 Nov 2025 | NAD+ | 7.0 | 15mg | 14.6mg | -2.4% | 96.73% | Lab F |
| 23 Nov 2025 | Semaglutide Oral | 4.8 | 20mg | 19.0mg | -5.1% | 97.80% | Lab A |
| 17 Nov 2025 | AA Water | 5.9 | 5mg | 4.3mg | -14.7% | 95.62% | Lab G |
| 17 Nov 2025 | Crystagen | 5.9 | 10mg | 9.8mg | -1.8% | 96.02% | Lab B |
| 17 Nov 2025 | Dihexa | 4.4 | 10mg | 10.7mg | +6.6% | 95.53% | Lab A |
| 17 Nov 2025 | Equipoise (Boldenone Undecylenate) | 6.0 | 250mg/ml | 224.4mg/ml | -10.2% | 97.66% | Lab B |
| 17 Nov 2025 | GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg | 5.4 | 100mg/ml | 122.7mg/ml | +22.7% | 96.52% | Lab A |
| 17 Nov 2025 | PEG MGF | 6.7 | 2mg | 1.9mg | -6.4% | 99.63% | Lab B |
| 17 Nov 2025 | PEG MGF | 6.5 | 30mg | 35.2mg | +17.3% | 97.85% | Lab G |
| 17 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.2 | 2mg | 2.2mg | +9.6% | 97.71% | Lab A |
| 14 Nov 2025 | AA Water | 7.3 | 5mg | 4.7mg | -6.4% | 97.80% | Lab G |
| 14 Nov 2025 | N-Acetyl Epitalon Amidate | 4.9 | 15mg | 15.9mg | +6.1% | 95.03% | Lab A |
| 14 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.3 | 50mg | 51.3mg | +2.7% | 95.77% | Lab G |
| 14 Nov 2025 | P21 | 7.5 | 5mg | 6.2mg | +24.7% | 99.55% | Lab C |
| 14 Nov 2025 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 6.2 | 10g | 10.5g | +5.0% | 97.83% | Lab G |
| 5 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.4 | 20mg | 20.1mg | +0.6% | 98.86% | Lab B |
| 5 Nov 2025 | Crystagen | 6.0 | 50mg | 42.8mg | -14.4% | 98.47% | Lab G |
| 5 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.0 | 10mg | 10.4mg | +3.6% | 98.05% | Lab D |
| 5 Nov 2025 | NAD+ | 5.3 | 20mg | 20.3mg | +1.7% | 97.68% | Lab G |
| 5 Nov 2025 | Selank 10mg + Semax 10mg Blend | 5.8 | 5mg | 5.3mg | +5.6% | 95.41% | Lab D |
| 4 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.5 | 30mg | 32.5mg | +8.2% | 96.40% | Lab C |
| 4 Nov 2025 | Dihexa | 6.6 | 50mg | 60.3mg | +20.6% | 98.36% | Lab D |
| 4 Nov 2025 | Humanin | 7.6 | 10mg | 10.4mg | +4.2% | 98.52% | Lab E |
| 4 Nov 2025 | Selank 10mg + Semax 10mg Blend | 6.2 | 2mg | 2.2mg | +10.4% | 96.85% | Lab C |
| 4 Nov 2025 | Semaglutide Oral | 6.5 | 10mg | 11.0mg | +10.1% | 96.77% | Lab D |
| 4 Nov 2025 | Semaglutide Oral | 4.5 | 50mg | 57.1mg | +14.1% | 99.43% | Lab B |
| 4 Nov 2025 | Winstrol Water (Stanozolol) | 6.2 | 100mg/ml | 98.5mg/ml | -1.5% | 95.13% | Lab E |
| 4 Nov 2025 | Winstrol Water (Stanozolol) | 8.5 | 200mg/ml | 247.1mg/ml | +23.6% | 99.26% | Lab A |
| 17 Oct 2025 | BPC157 5mg + TB500 5mg Blend | 6.0 | 10mg | 9.6mg | -3.8% | 99.19% | Lab B |
| 17 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.8 | 50mg | 58.9mg | +17.8% | 96.04% | Lab G |
| 17 Oct 2025 | NAD+ | 5.9 | 15mg | 15.9mg | +6.0% | 95.72% | Lab A |
| 17 Oct 2025 | P21 | 6.1 | 2mg | 2.2mg | +8.0% | 97.61% | Lab C |
| 17 Oct 2025 | Selank 10mg + Semax 10mg Blend | 8.6 | 10mg | 11.1mg | +10.5% | 96.66% | Lab C |
| 9 Oct 2025 | AA Water | 6.5 | 15mg | 15.4mg | +3.0% | 97.61% | Lab D |
| 9 Oct 2025 | MOTS-C | 4.0 | 30mg | 25.7mg | -14.4% | 95.00% | Lab B |
| 9 Oct 2025 | Orforglipron | 6.2 | 50mg | 61.0mg | +22.0% | 97.69% | Lab D |
| 9 Oct 2025 | Winstrol Water (Stanozolol) | 7.7 | 250mg/ml | 278.5mg/ml | +11.4% | 95.57% | Lab D |
| 3 Oct 2025 | Gonadorelin | 9.3 | 30mg | 31.2mg | +4.1% | 96.60% | Lab B |
| 3 Oct 2025 | PEG MGF | 5.4 | 2mg | 2.3mg | +15.1% | 96.42% | Lab F |
| 3 Oct 2025 | Winstrol Water (Stanozolol) | 8.4 | 300mg/ml | 315.1mg/ml | +5.0% | 95.09% | Lab D |